These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35758522)

  • 21. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.
    Taber DJ; Hunt KJ; Gebregziabher M; Srinivas T; Chavin KD; Baliga PK; Egede LE
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):131-139. PubMed ID: 27979979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-drug immunosuppression is associated with noninferior medium-term survival in pediatric heart transplant recipients.
    Watelle L; Touré M; Lamour JM; Kemna MS; Spinner JA; Hoffman TM; Carlo WF; Ballweg JA; Greenway SC; Dallaire F
    J Heart Lung Transplant; 2023 Aug; 42(8):1074-1081. PubMed ID: 36997361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
    Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
    JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
    Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
    Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart Transplantation.
    Huang X; Salerno D; Kovac D; Scheffert J; Hedvat J; Carver B; Choe J; Shertel T; Yuzefpolskaya M; Colombo PC; Jennings DL
    Clin Transplant; 2024 Aug; 38(8):e15420. PubMed ID: 39113661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.
    Bae S; Ahn JB; Joseph C; Whisler R; Schnitzler MA; Lentine KL; Kadosh BS; Segev DL; McAdams-DeMarco MA
    J Am Soc Nephrol; 2023 Jun; 34(6):1069-1077. PubMed ID: 36890643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.
    Werbel WA; Bae S; Yu S; Al Ammary F; Segev DL; Durand CM
    Am J Transplant; 2021 Feb; 21(2):717-726. PubMed ID: 32681603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes in African-Americans vs. Caucasians using thymoglobulin or interleukin-2 receptor inhibitor induction: analysis of USRDS database.
    Jindal RM; Das NP; Neff RT; Hurst FP; Falta EM; Elster EA; Abbott KC
    Am J Nephrol; 2009; 29(6):501-8. PubMed ID: 19060477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States.
    Riad SM; Lim N; Jackson S; Matas AJ; Lake J
    Liver Transpl; 2021 Nov; 27(11):1553-1562. PubMed ID: 34145949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis.
    Lentine KL; Cheungpasitporn W; Xiao H; McAdams-DeMarco M; Lam NN; Segev DL; Bae S; Ahn JB; Hess GP; Caliskan Y; Randall HB; Kasiske BL; Schnitzler MA; Axelrod DA
    Transplantation; 2021 Aug; 105(8):1840-1849. PubMed ID: 33214534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
    Budde K; Prashar R; Haller H; Rial MC; Kamar N; Agarwal A; de Fijter JW; Rostaing L; Berger SP; Djamali A; Leca N; Allamassey L; Gao S; Polinsky M; Vincenti F
    J Am Soc Nephrol; 2021 Dec; 32(12):3252-3264. PubMed ID: 34706967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of cytomegalovirus in cardiac transplant recipients receiving induction immunosuppression with antithymocyte globulin.
    Jewani PK; Pouch SM; Kissling KT
    Clin Transplant; 2018 Nov; 32(11):e13420. PubMed ID: 30290013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction.
    Patel SJ; Suki WN; Loucks-DeVos J; Graviss EA; Nguyen DT; Knight RJ; Kuten SA; Moore LW; Teeter LD; Gaber LW; Gaber AO
    Transpl Int; 2016 Aug; 29(8):897-908. PubMed ID: 27196395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.